• 5795 Citations
  • 32 h-Index
1991 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 5795 Citations
  • 32 h-Index
  • 118 Article
  • 6 Review article
  • 5 Letter
  • 1 Comment/debate
Review article

A csontvelô eredetû ôssejtek megjelenése az ép vastagbélhámban és a gyulladást követô hámregenerációban.

Translated title of the contribution: Appearing of bone marrow derived stem cells in healthy and regenerating colonic epitheliumValcz, G., Krenács, T., Sipos, F., Wichmann, B., Tóth, K., Leiszter, K., Balogh, Z., Csizmadia, A., Hagymási, K., Muzes, G., Masszi, T., Molnár, B. & Tulassay, Z., Oct 4 2009, In : Orvosi hetilap. 150, 40, p. 1852-1857 6 p.

Research output: Contribution to journalReview article

4 Citations (Scopus)

A krónikus myeloid leukaemia korszerũ diagnosztikája és kezelése

Translated title of the contribution: Chronic myelogenous leukemia: Diagnosis and treatmentDemeter, J., Poros, A., Bödör, C., Horváth, L. & Masszi, T., Sep 1 2016, In : Orvosi Hetilap. 157, 37, p. 1459-1468 10 p.

Research output: Contribution to journalReview article

1 Citation (Scopus)

Csontvelo-transzplantáció az imatinib korszakban

Translated title of the contribution: Stem cell transplantation in the imatinib eraMasszi, T., Dec 1 2005, In : Orvosi hetilap. 146, 18 SUPPL.1, p. 900-904 5 p.

Research output: Contribution to journalReview article

2 Citations (Scopus)

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature

Varga, G., Mikala, G., Gopcsa, L., Csukly, Z., Kollai, S., Balázs, G., Botond, T., Wohner, N., Horváth, L., Szombath, G., Farkas, P. & Masszi, T., Apr 23 2018, In : Journal of Oncology. 2018, 3970169.

Research output: Contribution to journalReview article

3 Citations (Scopus)

Sinusoidal obstruction syndrome/veno-occlusive disease: Current situation and perspectives - A position statement from the European Society for Blood and Marrow Transplantation (EBMT)

Mohty, M., Malard, F., Abecassis, M., Aerts, E., Alaskar, A. S., Aljurf, M., Arat, M., Bader, P., Baron, F., Bazarbachi, A., Blaise, D., Ciceri, F., Corbacioglu, S., Dalle, J. H., Duarte, R. F., Fukuda, T., Huynh, A., Masszi, T., Michallet, M., Nagler, A. & 10 others, Nichonghaile, M., Pagluica, A., Peters, C., Petersen, F. B., Richardson, P. G., Ruutu, T., Savani, B. N., Wallhult, E., Yakoub-Agha, I. & Carreras, E., Jun 4 2015, In : Bone Marrow Transplantation. 50, 6, p. 781-789 9 p.

Research output: Contribution to journalReview article

138 Citations (Scopus)

Uj, sugárzásmentes csontvelö-transzplantációs kondicionáló kezelés dibróm-mannitollal krónikus myeloid leukaemiában.

Translated title of the contribution: A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemiaKelemen, E., Dénes, R., Barta, A., Masszi, T., Reményi, P., Pálóczi, K., Bátai, A., Torbágyo, E., Sipos, A., Lengyel, L., Jakab, K., Gyódi, E., Réti, M., Földi, J., Páldi-Haris, P., Manuel, A., Fekete, S., Török, J., Hoffer, I., Jakab, J. & 2 others, Váradi, G. & Petrányi, G., Aug 23 1998, In : Orvosi hetilap. 139, 34, p. 2003-2001; discussion 2011-2012

Research output: Contribution to journalReview article

2 Citations (Scopus)
Letter

CIDP cured by allogeneic hematopoietic stem cell transplantation [1]

Reményi, P., Masszi, T., Borbényi, Z., Soós, J., Siklós, L. & Engelhardt, J. I., Aug 1 2007, In : European Journal of Neurology. 14, 8, p. e1-e2

Research output: Contribution to journalLetter

26 Citations (Scopus)

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide

Harrison, C. N., Griesshammer, M., Miller, C., Masszi, T., Passamonti, F., Zachee, P., Durrant, S., Pane, F., Guglielmelli, P., Verstovsek, S., Jones, M. M., Hunter, D. S., Sun, W., Li, J., Khan, M., Habr, D. & Kiladjian, J. J., Jul 2018, In : British Journal of Haematology. 182, 2, p. 279-284 6 p.

Research output: Contribution to journalLetter

1 Citation (Scopus)

JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia

Andrikovics, H., Nahajevszky, S., Koszarska, M., Meggyesi, N., Bors, A., Halm, G., Lueff, S., Lovas, N., Matrai, Z., Csomor, J., Rasonyi, R., Egyed, M., Varkonyi, J., Mikala, G., Sipos, A., Kozma, A., Adam, E., Fekete, S., Masszi, T. & Tordai, A., Oct 2010, In : Leukemia. 24, 10, p. 1809-1813 5 p.

Research output: Contribution to journalLetter

18 Citations (Scopus)

Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exon [1]

Paldi-Haris, P., Barta, A., Lengyel, L., Batai, A., Masszi, T., Remenyi, P., Denes, R., Paloczi, K., Kelemen, E. & Foldi, J., Jan 1 1994, In : Leukemia. 8, 10, 1 p.

Research output: Contribution to journalLetter

9 Citations (Scopus)

Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation [4]

Masszi, T., Farkas, A., Remenyi, P., Lueff, S., Batai, A., Krivan, G., Kemeny, L., Dobozy, A. & Reti, M., Nov 1 2005, In : Dermatology. 212, 1, p. 88-89 2 p.

Research output: Contribution to journalLetter

7 Citations (Scopus)
Article

A 2-es típusú Janus tirozin kináz Val617Phe aktiváló pontmutáció szerepe és kimutatásának jelentosége myeloproliferatív szindrómában

Translated title of the contribution: Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detectionAndrikovics, H., Szilvási, A., Meggyesi, N., Király, V., Halm, G., Lueff, S., Nahajevszky, S., Mikala, G., Sipos, A., Lovas, N., Csukly, Z., Mátrai, Z., Tamáska, J., Tordai, A. & Masszi, T., Feb 4 2007, In : Orvosi hetilap. 148, 5, p. 203-210 8 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

Gézsi, A., Budde, U., Deák, I., Nagy, E., Mohl, A., Schlammadinger, Á., Boda, Z., Masszi, T., Sadler, J. E. & Bodó, I., Jun 1 2010, In : Journal of Thrombosis and Haemostasis. 8, 6, p. 1273-1280 8 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

Meggyesi, N., Kozma, A., Halm, G., Nahajevszky, S., Bátai, Á., Fekete, S., Barta, A., Ujj, G., Lueff, S., Sipos, A., Ádám, E., Bors, A., Reményi, P., Masszi, T., Tordai, A. & Andrikovics, H., Dec 1 2011, In : Acta Haematologica. 127, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)

Akut szívizom-infarctusban végzett elso magyar autológ csontveloi ossejt transzplantációk során szerzett tapasztalataink

Translated title of the contribution: Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarctionVértesljai, M., Piróth, Z., Fontos, G., Tóth, A., Simor, T., Lueff, S., Reményi, P., Réti, M., Masszi, T. & Andréka, P., Jan 8 2006, In : Orvosi hetilap. 147, 1, p. 3-6 4 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Allogeneic bone marrow transplantation for acute leukaemia - IGCI experience

Labar, B., Masszi, T., Morabito, F., Mistrik, M., Holowiecki, J., Bogdaníc, V., Nemet, D., Mrsić, M., Krieger, O. & Lutz, D., Jun 1 1996, In : Bone Marrow Transplantation. 17, 6, p. 1009-1012 4 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Allogeneic bone marrow transplantation for acute leukemia in adults

Masszi, T., Reményi, P., Kriván, G., Goda, V. & Réti, M., Dec 1 1998, In : Bone Marrow Transplantation. 22, SUPPL. 4, p. S77-S79

Research output: Contribution to journalArticle

1 Citation (Scopus)

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: Comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus cy as conditioning regimen-A report from the acute leukemia working party of theeuropean group for blood and marrow transplantation

Nagler, A., Rocha, V., Labopin, M., Unal, A., Ben Othman, T., Campos, A., Volin, L., Poire, X., Aljurf, M., Masszi, T., Socie, G., Sengelov, H., Michallet, M., Passweg, J., Veelken, H., Yakoub-Agha, I., Shimoni, A. & Mohty, M., Oct 1 2013, In : Journal of Clinical Oncology. 31, 28, p. 3549-3556 8 p.

Research output: Contribution to journalArticle

82 Citations (Scopus)

Allogen transzplantacio periferias haemopoeticus ossejtekkel

Translated title of the contribution: Allogeneic peripheral blood stem cell transplantationMasszi, T., Oct 2 1997, In : Lege Artis Medicinae. 7, 1-2, p. 42-45 4 p.

Research output: Contribution to journalArticle

A myeloma multiplex bortezomibalapú kezelése: Hazai tapasztalatok az elso 60 beteg adatainak tükrében

Translated title of the contribution: Single-site experience with bortezomib-based therapy of multiple myeloma: Treatment results of 60 patientsGábor, M., Árpád, B., Andrea, C., Zoltán, C., János, D., Gabriella, H., Judit, J., Balázs, K., Nóra, L., Sándor, L., Mónika, P., Péter, R., Andrea, S., Zsuzsanna, T. & Tamás, M., Jan 1 2007, In : Lege Artis Medicinae. 17, 1, p. 26-34 9 p.

Research output: Contribution to journalArticle

An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary

Mohl, A., Marschalek, R., Masszi, T., Nagy, E., Obser, T., Oyen, F., Sallai, K., Bodó, I. & Schneppenheim, R., Sep 30 2008, In : Journal of Thrombosis and Haemostasis. 6, 10, p. 1729-1735 7 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Analyses of donor-derived keratinocytes in hairy and nonhairy skin biopsies of female patients following allogeneic male bone marrow transplantation

Nemeth, K., Key, S., Bottlik, G., Masszi, T., Mezey, E. & Karpati, S., Jan 1 2012, In : Stem Cells and Development. 21, 1, p. 152-157 6 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixafor

Sureda, A., Chabannon, C., Masszi, T., Pohlreich, D., Scheid, C., Thieblemont, C., Wahlin, B. E., Sakellari, I., Russell, N., Janikova, A., Dabrowska-Iwanicka, A., Touzeau, C., Esquirol, A., Jantunen, E., van der Werf, S., Bosman, P., Boumendil, A., Liu, Q., Celanovic, M., Montoto, S. & 1 others, Dreger, P., Mar 1 2020, In : Bone Marrow Transplantation. 55, 3, p. 613-622 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Analysis of platelet α2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy

Béres, B. J., Tóth-Zsámboki, E., Vargová, K., László, Á., Masszi, T., Kerecsen, G., Préda, I. & Kiss, R. G., Nov 1 2008, In : Thrombosis and Haemostasis. 100, 5, p. 829-836 8 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma

Orlowski, R. Z., Gercheva, L., Williams, C., Sutherland, H., Robak, T., Masszi, T., Goranova-Marinova, V., Dimopoulos, M. A., Cavenagh, J. D., Špička, I., Maiolino, A., Suvorov, A., Bladé, J., Samoylova, O., Puchalski, T. A., Reddy, M., Bandekar, R., van de Velde, H., Xie, H. & Rossi, J. F., Jan 1 2015, In : American Journal of Hematology. 90, 1, p. 42-49 8 p.

Research output: Contribution to journalArticle

71 Citations (Scopus)

Apoptosis induction by retinoids in eosinophilic leukemia cells: Implication of retinoic acid receptor-α signaling in all-trans-retinoic acid hypersensitivity

Robert, C., Delva, L., Balitrand, N., Nahajevszky, S., Masszi, T., Chomienne, C. & Papp, B., Jun 15 2006, In : Cancer Research. 66, 12, p. 6336-6344 9 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)

A randomized phase 3 study of tipifarnib compared with best supportive care, including hydroxyurea, in the treatment of newly diagnosed acute myeloid leukemia in patients 70 years or older

Harousseau, J. L., Martinelli, G., Jedrzejczak, W. W., Brandwein, J. M., Bordessoule, D., Masszi, T., Ossenkoppele, G. J., Alexeeva, J. A., Beutel, G., Maertens, J., Vidriales, M. B., Dombret, H., Thomas, X., Burnett, A. K., Robak, T., Khuageva, N. K., Golenkov, A. K., Tothova, E., Mollgard, L., Park, Y. C. & 3 others, Bessems, A., De Porre, P. & Howes, A. J., Nov 19 2009, In : Blood. 114, 6, p. 1166-1173 8 p.

Research output: Contribution to journalArticle

99 Citations (Scopus)

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Hájek, R., Masszi, T., Petrucci, M. T., Palumbo, A., Rosiñol, L., Nagler, A., Yong, K. L., Oriol, A., Minarik, J., Pour, L., Dimopoulos, M. A., Maisnar, V., Rossi, D., Kasparu, H., van Droogenbroeck, J., Yehuda, D. B., Hardan, I., Jenner, M., Calbecka, M., Dávid, M. & 12 others, de la Rubia, J., Drach, J., Gasztonyi, Z., Górnik, S., Leleu, X., Munder, M., Offidani, M., Zojer, N., Rajangam, K., Chang, Y. L., San-Miguel, J. F. & Ludwig, H., Jul 15 2016, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

59 Citations (Scopus)

Autologus blood/marrow transplantation: Autologous stem cell transplantation for malignant lymphomas

Reményi, P., Masszi, T., Kriván, G., Goda, V. & Réti, M., Dec 1 1998, In : Bone Marrow Transplantation. 22, SUPPL. 4, p. S104-S106

Research output: Contribution to journalArticle

1 Citation (Scopus)

Belinostat in patients with relapsed or refractory peripheral T-cell lymphoma: Results of the pivotal phase II BELIEF (CLN-19) study

O'Connor, O. A., Horwitz, S., Masszi, T., Van Hoof, A., Brown, P., Doorduijn, J., Hess, G., Jurczak, W., Knoblauch, P., Chawla, S., Bhat, G., Choi, M. R., Walewski, J., Savage, K., Foss, F., Allen, L. F. & Shustov, A., Aug 10 2015, In : Journal of Clinical Oncology. 33, 23, p. 2492-2499 8 p.

Research output: Contribution to journalArticle

177 Citations (Scopus)

Bone marrow transplantation in non-malignant disorders

Kriván, G., Timár, L., Goda, V., Réti, M., Reményi, P. & Masszi, T., Dec 1 1998, In : Bone Marrow Transplantation. 22, SUPPL. 4, p. S80-S83

Research output: Contribution to journalArticle

6 Citations (Scopus)

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up

Ludwig, H., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., Dmoszynska, A., Paiva, B., Vidriales, M. B., Esteves, G., Stoppa, A. M., Robinson, D., Chaturvedi, S., Ataman, O., Enny, C., Feng, H., van de Velde, H. & Viterbo, L., Nov 2015, In : British Journal of Haematology. 171, 3, p. 344-354 11 p.

Research output: Contribution to journalArticle

18 Citations (Scopus)

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

Gambacorti-Passerini, C., Brümmendorf, T. H., Kim, D. W., Turkina, A. G., Masszi, T., Assouline, S., Durrant, S., Kantarjian, H. M., Khoury, H. J., Zaritskey, A., Shen, Z. X., Jin, J., Vellenga, E., Pasquini, R., Mathews, V., Cervantes, F., Besson, N., Turnbull, K., Leip, E., Kelly, V. & 1 others, Cortes, J. E., Jul 2014, In : American Journal of Hematology. 89, 7, p. 732-742 11 p.

Research output: Contribution to journalArticle

66 Citations (Scopus)

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): A randomised, double-blind, placebo-controlled, phase 3 trial

Moskowitz, C. H., Nademanee, A., Masszi, T., Agura, E., Holowiecki, J., Abidi, M. H., Chen, A. I., Stiff, P., Gianni, A. M., Carella, A., Osmanov, D., Bachanova, V., Sweetenham, J., Sureda, A., Huebner, D., Sievers, E. L., Chi, A., Larsen, E. K., Hunder, N. N. & Walewski, J., May 9 2015, In : The Lancet. 385, 9980, p. 1853-1862 10 p.

Research output: Contribution to journalArticle

323 Citations (Scopus)

Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms

Mózes, R., Gángó, A., Sulák, A., Vida, L., Reiniger, L., Timár, B., Krenács, T., Alizadeh, H., Masszi, T., Gaál-Weisinger, J., Demeter, J., Csomor, J., Matolcsy, A., Kajtár, B. & Bödör, C., Apr 2019, In : Pathology. 51, 3, p. 301-307 7 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma

ASPIRE Investigators, Jan 8 2015, In : New England Journal of Medicine. 372, 2, p. 142-152 11 p.

Research output: Contribution to journalArticle

630 Citations (Scopus)

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): And randomised, phase 3, open-label, multicentre study

Dimopoulos, M. A., Moreau, P., Palumbo, A., Joshua, D., Pour, L., Hájek, R., Facon, T., Ludwig, H., Oriol, A., Goldschmidt, H., Rosiñol, L., Straub, J., Suvorov, A., Araujo, C., Rimashevskaya, E., Pika, T., Gaidano, G., Weisel, K., Goranova-Marinova, V., Schwarer, A. & 11 others, Minuk, L., Masszi, T., Karamanesht, I., Offidani, M., Hungria, V., Spencer, A., Orlowski, R. Z., Gillenwater, H. H., Mohamed, N., Feng, S. & Chng, W. J., Jan 1 2016, In : The Lancet Oncology. 17, 1, p. 27-38 12 p.

Research output: Contribution to journalArticle

370 Citations (Scopus)

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide- dexamethasone in relapsed multiple myeloma by previous treatment

Dimopoulos, M. A., Stewart, A. K., Masszi, T., Spicka, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D., Mihaylov, G. G., Goranova-Marinova, V., Rajnics, P., Suvorov, A., Niesvizky, R., Jakubowiak, A., San-Miguel, J., Ludwig, H., Ro, S., Aggarwal, S., Moreau, P. & Palumbo, A., Jan 1 2017, In : Blood Cancer Journal. 7, 4, e554.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

Avet-Loiseau, H., Fonseca, R., Siegel, D., Dimopoulos, M. A., Špička, I., Masszi, T., Hájek, R., Rosiñol, L., Goranova-Marinova, V., Mihaylov, G., Maisnar, V., Mateos, M. V., Wang, M., Niesvizky, R., Oriol, A., Jakubowiak, A., Minarik, J., Palumbo, A., Bensinger, W., Kukreti, V. & 4 others, Ben-Yehuda, D., Stewart, A. K., Obreja, M. & Moreau, P., Sep 1 2016, In : Blood. 128, 9, p. 1174-1180 7 p.

Research output: Contribution to journalArticle

59 Citations (Scopus)

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

Mesa, R., Verstovsek, S., Kiladjian, J. J., Griesshammer, M., Masszi, T., Durrant, S., Passamonti, F., Harrison, C. N., Pane, F., Zachee, P., Zhen, H., Jones, M. M., Parasuraman, S., Li, J., Côté, I., Habr, D. & Vannucchi, A. M., Aug 1 2016, In : European journal of haematology. 97, 2, p. 192-200 9 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Characterization and function of histamine receptors in human bone marrow stromal cells

Nemeth, K., Wilson, T., Rada, B., Parmelee, A., Mayer, B., Buzas, E., Falus, A., Key, S., Masszi, T., Karpati, S. & Mezey, E., Feb 1 2012, In : Stem Cells. 30, 2, p. 222-231 10 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)
6 Citations (Scopus)

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin

Skribek, H., Otvos, R., Flaberg, E., Nagy, N., Markasz, L., Eksborg, S., Masszi, T., Kozma, A., Adam, E., Miseta, A., Klein, E. & Szekely, L., Dec 1 2010, In : Experimental Hematology. 38, 12, p. 1219-1230 12 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

Mohl, A., Boda, Z., Jager, R., Losonczy, H., Marosi, A., Masszi, T., Nagy, E., Nemes, L., Obser, T., Oyen, F., Radványi, G., Schlammadinger, Á., Szélessy, Z. S., Várkonyi, A., Vezendy, K., Vilimi, B., Schneppenheim, R. & Bodó, I., May 1 2011, In : Journal of Thrombosis and Haemostasis. 9, 5, p. 945-952 8 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT

Giebel, S., Labopin, M., Potter, M., Poiré, X., Sengeloev, H., Socié, G., Huynh, A., Afanasyev, B. V., Schanz, U., Ringden, O., Kalhs, P., Beelen, D. W., Campos, A. M., Masszi, T., Canaani, J., Mohty, M. & Nagler, A., Jun 1 2018, In : European Journal of Cancer. 96, p. 73-81 9 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)

Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100

Krahling, T., Balassa, K., Kiss, K. P., Bors, A., Batai, A., Halm, G., Egyed, M., Fekete, S., Remenyi, P., Masszi, T., Tordai, A. & Andrikovics, H., Jan 1 2016, In : Cancer Epidemiology Biomarkers and Prevention. 25, 1, p. 98-104 7 p.

Research output: Contribution to journalArticle

14 Citations (Scopus)

Csontveló-transzplantációs program Magyarországon: beszámoló az 1990-1995 közötti idószakról.

Translated title of the contribution: The bone-marrow transplantation program in Hungary: report from the period 1990-1995Petrányi, G., Masszi, T., Tímár, L., Kriván, G., Pálóczi, K., Nagy, K., Fekete, S., Reményi, P., Torbágyi, E., Dénes, R. & Kelemen, E., Oct 6 1996, In : Orvosi hetilap. 137, 40, p. 2203-2208 6 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan-Khan, A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P., Aug 25 2016, In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticle

505 Citations (Scopus)

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: Efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

Saglio, G., Hochhaus, A., Goh, Y. T., Masszi, T., Pasquini, R., Maloisel, F., Erben, P., Cortes, J., Paquette, R., Bradley-Garelik, M. B., Zhu, C. & Dombret, H., Aug 15 2010, In : Cancer. 116, 16, p. 3852-3861 10 p.

Research output: Contribution to journalArticle

87 Citations (Scopus)